Remicade® infliximab

Find a Specialist | Contact Us | For Healthcare Professionals

How REMICADE WorksHow REMICADE Is Given Lives Changed by REMICADEImportant Safety Information


 

How REMICADE Is Given (IV Infusion)

REMICADE is given by IV infusion, a simple process that usually takes about two hours. A healthcare professional administers the treatment in a supervised environment, which is either a physician's office or a treatment center. You will receive your first dose followed by additional doses at two and six weeks after the first dose. You will then receive a dose every eight weeks. If you have ankylosing spondylitis, you will receive treatment every six weeks.

With REMICADE, all you have to do is come for your appointment. Your healthcare professional will carefully calculate the dosage customized to your weight so that you get the best response to the treatment. Individual results may vary.

Three Steps of the Infusion Process

The infusion process can be summarized in three steps:

  1. Preparation: When you're ready for your infusion, a healthcare professional — such as a nurse — will weigh you to calculate the dosage of REMICADE that's right for you. The nurse will also check your blood pressure, pulse, and temperature before the infusion begins.
  2. IV Placement: The nurse will then insert a narrow IV needle into your arm after you have been comfortably seated. When the nurse places the IV in your arm, you may feel a slight pinching sensation, but only for a second. The IV will be held in place on your arm with tape, and the infusion will begin. If you are not comfortable at any point during the infusion, let the nurse know.
  3. Relax: During your infusion, the nurse will check on you at regular intervals. During this time, you can relax, read a book, catch up on some work, watch TV or a movie, or listen to music.

IMPORTANT SAFETY INFORMATION | Privacy Policy | Legal Notice | Site Map | About Centocor Ortho Biotech Inc.

© Centocor Ortho Biotech Inc. 1999-2009
This site is published by Centocor Ortho Biotech Inc. which is solely responsible for its contents.
It is intended for residents from the United States.
Last Updated: January 19, 2009